Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Etifoxine analgesia in experimental monoarthritis: A combined action that protects spinal inhibition and limits central inflammatory processes
Maya Aouad, Vivien Zell, Pierre‐Éric Juif, et al.
Pain (2013) Vol. 155, Iss. 2, pp. 403-412
Closed Access | Times Cited: 20

Showing 20 citing articles:

A TSPO ligand attenuates brain injury after intracerebral hemorrhage
Minshu Li, Honglei Ren, Kevin N. Sheth, et al.
The FASEB Journal (2017) Vol. 31, Iss. 8, pp. 3278-3287
Open Access | Times Cited: 62
Anxiolytics targeting GABAA receptors: Insights on etifoxine
Pierrick Poisbeau, Géraldine Gazzo, Laurent Calvel
The World Journal of Biological Psychiatry (2018) Vol. 19, Iss. sup1, pp. S36-S45
Open Access | Times Cited: 38
Etifoxine for Pain Patients with Anxiety
Yun-Mi Choi, Kyung-Hoon Kim
The Korean journal of pain (2015) Vol. 28, Iss. 1, pp. 4-10
Open Access | Times Cited: 37
A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury
Han-Dong Li, Minshu Li, Elaine Shi, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Cholecalciferol (Vitamin D3) Reduces Rat Neuropathic Pain by Modulating Opioid Signaling
Pierrick Poisbeau, Maya Aouad, Géraldine Gazzo, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7208-7221
Open Access | Times Cited: 33
Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone
Pierrick Poisbeau, Anne Florence Keller, Maya Aouad, et al.
Frontiers in Cellular Neuroscience (2014) Vol. 8
Open Access | Times Cited: 33
Differential effects of the 18-kDa translocator protein (TSPO) ligand etifoxine on steroidogenesis in rat brain, plasma and steroidogenic glands: Pharmacodynamic studies
Philippe Lière, Antoine Pianos, Jean‐Paul Oudinet, et al.
Psychoneuroendocrinology (2017) Vol. 83, pp. 122-134
Closed Access | Times Cited: 33
<p>An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action</p>
Philippe Nuss, Florian Ferreri, Michel Bourin
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 1781-1795
Open Access | Times Cited: 28
Reduction of Traumatic Brain Damage by Tspo Ligand Etifoxine
Mona Shehadeh, Eilam Palzur, Liat Apel, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2639-2639
Open Access | Times Cited: 23
Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling
Xiaojuan Shi, Chengfei Gao, Lin Wang, et al.
Toxicon (2019) Vol. 178, pp. 33-40
Closed Access | Times Cited: 20
The translocator protein as a drug target in Alzheimer’s disease
Sook Wern Chua, Michael Kassiou, Lars M. Ittner
Expert Review of Neurotherapeutics (2014) Vol. 14, Iss. 4, pp. 439-448
Closed Access | Times Cited: 21
Analgesic and anti-edemic properties of etifoxine in models of inflammatory sensitization
Géraldine Gazzo, Philippe Girard, Nisrine Kamoun, et al.
European Journal of Pharmacology (2018) Vol. 843, pp. 316-322
Closed Access | Times Cited: 12
Long-lasting analgesic and neuroprotective action of the non-benzodiazepine anxiolytic etifoxine in a mouse model of neuropathic pain
Nisrine Kamoun, Géraldine Gazzo, Yannick Goumon, et al.
Neuropharmacology (2020) Vol. 182, pp. 108407-108407
Open Access | Times Cited: 10
Characterization of the fast GABAergic inhibitory action of etifoxine during spinal nociceptive processing in male rats
Pierre‐Éric Juif, Meggane Melchior, Pierrick Poisbeau
Neuropharmacology (2014) Vol. 91, pp. 117-122
Closed Access | Times Cited: 9
In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models
Véronique Riban, Johann Meunier, Dorothée Buttigieg, et al.
CNS & Neurological Disorders - Drug Targets (2020) Vol. 19, Iss. 3, pp. 227-240
Closed Access | Times Cited: 7
The non-benzodiazepine anxiolytic etifoxine limits mechanical allodynia and anxiety-like symptoms in a mouse model of streptozotocin-induced diabetic neuropathy
Géraldine Gazzo, Marlene Salgado Ferrer, Pierrick Poisbeau
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0248092-e0248092
Open Access | Times Cited: 5
Effectiveness of bis(phenylimidazoselenazolyl) diselenide on a mouse model of inflammatory nociception
Pietro Maria Chagas, Bruna C.W. Fulco, Ana Paula Pesarico, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 96, pp. 56-63
Closed Access | Times Cited: 4
Comorbid anxiety disorders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment strategy
Н. Г. Незнанов, M. М. Tanashyan, Е. С. Акарачкова, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 12, pp. 126-126
Closed Access
The translocator protein as a drug target in Alzheimer's
Sook Wern Chua, Michael Kassiou, Lars M. Ittner
(2014)
Closed Access
The non-benzodiazepine anxiolytic etifoxine limits the sensory-affective expression of pain following streptozotocin-induced diabetic neuropathy
Géraldine Gazzo, Marlene Salgado Ferrer, Pierrick Poisbeau
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top